A detailed history of Stanley Laman Group, Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Stanley Laman Group, Ltd. holds 64,491 shares of AZN stock, worth $4.85 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
64,491
Previous 62,329 3.47%
Holding current value
$4.85 Million
Previous $4.86 Million 3.37%
% of portfolio
0.78%
Previous 0.76%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$76.67 - $87.62 $165,760 - $189,434
2,162 Added 3.47%
64,491 $5.03 Million
Q2 2024

Jul 18, 2024

BUY
$66.81 - $80.83 $178,716 - $216,220
2,675 Added 4.48%
62,329 $4.86 Million
Q1 2024

Apr 17, 2024

BUY
$61.03 - $69.57 $25,937 - $29,567
425 Added 0.72%
59,654 $4.04 Million
Q4 2023

Feb 02, 2024

BUY
$61.89 - $69.28 $388,483 - $434,870
6,277 Added 11.85%
59,229 $3.99 Million
Q3 2023

Oct 16, 2023

BUY
$64.85 - $71.7 $3.43 Million - $3.8 Million
52,952 New
52,952 $3.59 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Stanley Laman Group, Ltd. Portfolio

Follow Stanley Laman Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stanley Laman Group, Ltd. with notifications on news.